Brief: GT Biopharma Announces Ind Submission For GTB-3650 For Treatment Of CD33+ Leukemia

GT Biopharma

04/12/2023 14:32

Dec 4 (Reuters) - GT Biopharma Inc  GTBP.O :
    * GT BIOPHARMA ANNOUNCES IND SUBMISSION FOR GTB-3650 FOR
TREATMENT
OF CD33+ LEUKEMIA

Source text for Eikon:  ID:nGNX7Q1PSh 
Further company coverage:  GTBP.O 

 ((reuters.briefs@thomsonreuters.com;))